Osteoarthritis and Bone Disorders News

Published results showed an association between hip corticosteroid injections and rapidly destructive hip disease.

Healio announced the launch of Rheum and Boards, a quiz-based, online learning resource for rheumatologists, according to a Healio press release.

Hip fracture hospitalizations decreased by 11% in France during the first COVID-19 lockdown compared with the year before, according to a speaker at the American Society for Bone and Mineral Research Annual Meeting.

TPX-100, a novel 23-amino acid peptide, has a “significant effect” on bone shape, as measured by B-score, in knee osteoarthritis and shows promise as a disease-modifying drug, according to data published in Arthritis Research & Therapy.

Race was not a “substantial, independent predictor” of functional outcomes following total knee replacement, but marginal differences in care were observed across treatment settings, according to data published in Arthritis Care & Research.

Discrepancies between clinical practice guideline documents highlight the over-arching controversies in osteoporosis management, according to a presenter at the 2021 Congress of Clinical Rheumatology-West.

A reminder of some common and not-so-common clinical scenarios can make every rheumatologist more capable of delivering optimal patient care, according to a presenter at the 2021 Congress of Clinical Rheumatology-West.

Among patients with arthritis, receiving exercise recommendations from a physician is “critical” to meeting physical activity guidelines and relieving symptom burden, regardless of race and ethnicity, researchers noted in BMC Public Health.

Clinicians need to be aware of the contents of the June 3 memo from the FDA regarding use of human cell and tissue products and must realize that the guidance issued Nov. 15, 2017, has not changed, according to a regulatory consultant.

It will be “many years” before any new pharmacologic osteoporosis therapies are approved, as there are currently no new drugs in phase 2 or 3 development, according to a speaker at the 2021 Congress of Clinical Rheumatology-East meeting.